Uses of Bremelanotide in Therapy for Female Sexual Dysfunction

摘要

Use of a subcutaneously administered dose of between about 1.0 mg and 1.75 mg of bremelanotide or a pharmaceutically acceptable salt of bremelanotide for the treatment of female sexual dysfunction in women while reducing or minimizing undesirable side effects.

主权项

1. A method for treating female sexual dysfunction in a female patient diagnosed with female sexual dysfunction but anticipating sexual activity, while reducing or minimizing side effects associated with the administration of bremelanotide, comprising
administering the female patient by subcutaneous injection a composition comprising no more than about 1.75 mg of bremelanotide or a pharmaceutically acceptable salt of bremelanotide, thereby treating female sexual dysfunction while reducing or minimizing side effects compared to intranasal administration of an equivalent dosage of bremelanotide or a pharmaceutically acceptable salt of bremelanotide.